KeriCure Medical is a biotechnology company specializing in novel, cost effective wound care products. KeriCure was formed to commercialize an advanced platform polymer technology developed by Dr. Kerriann Greenhalgh, Founder and CEO of KeriCure. The KeriCure Medical team consists of a strong group of PhD scientists, regulatory and quality experts, and entrepreneurs, who all have successful endeavors in medical device startups, along with a solid group of active advisors lending their time and experience to help build KeriCure Medical. Our technology permits incorporation of a variety of FDA approved antimicrobials and other additives beneficial to wound healing, uniquely situating the KeriCure products ahead of the competition. KeriCure Medical is breathing new life into the stagnant wound care dressing market.